Delivering the right behavioural ingredients for the moment,...
Lirio's Dr Amy Bucher discusses the risks of the declining trust in healthcare institutions from a behavioural science perspective.
Newsletters and Deep Dive digital magazine
Lirio's Dr Amy Bucher discusses the risks of the declining trust in healthcare institutions from a behavioural science perspective.
Patrick Leung – chief technology officer at Faro Health – discusses how AI can transform clinical trials.
Dive into a conversation on women in AI, with: Kate Eversole, Pharma Brands; Celine Parmentier, Real Chemistry; and Emma Slade, Tangram Therapeutics.
Dr Alan Roth, CEO of Oxford Drug Design, discusses the use of AI to accelerate discovery of new treatments.
Benedict Cross, Chief Technology Officer at PhoreMost, discusses targeted protein degradation.
Editor's Picks
Newsletters and Deep Dive
digital magazine